Related Experiment Videos
Progress in producing knockout models for xenotransplantation by nuclear transfer.
Liangxue Lai1, Randall S Prather
1Department of Animal Sciences, University of Missouri-Columbia, Columbia, MO 65211, USA.
Annals of Medicine
|January 30, 2003
Summary
Genetically modifying pigs by inactivating the GGTA1 gene is a key step to prevent hyperacute rejection in xenotransplantation. This advancement aims to overcome a major hurdle in using pig organs for human transplants.
Area of Science:
- Biomedical Science
- Xenotransplantation Research
- Genetic Engineering in Swine
Background:
- Pigs are the primary non-human source for xenotransplantation due to physiological similarities with humans.
- Human natural antibody-mediated hyperacute rejection (HAR) is a significant barrier to successful pig-to-human organ transplantation.
- The alpha(1,3)galactosyltransferase (GGTA1) gene is responsible for producing the Gal antigen, a target of human antibodies causing HAR.
Purpose of the Study:
- To genetically modify pigs by inactivating the GGTA1 gene to prevent hyperacute and delayed vascular rejection.
- To establish a foundation for future studies investigating the role of anti-Gal antibodies in xenograft rejection.
- To enable the evaluation of xenotransplantation efficacy in non-human primate models without HAR complications.
Main Methods:
- Detailed characterization of the GGTA1 gene's structure and function.
- Advancement of DNA transfection techniques for porcine somatic cells.
- Optimization of nuclear transfer (NT) procedures in pigs.
- Specific genetic modification of one GGTA1 gene copy to create a non-functional allele.
Main Results:
- A method for creating a non-functional GGTA1 gene in pigs has been successfully developed.
- The genetic modification strategy targets the key enzyme responsible for the Gal antigen.
- Achieving GGTA1 homozygosity in pigs is the next critical step for experimental validation.
Conclusions:
- Inactivating the GGTA1 gene in pigs is a crucial strategy to mitigate hyperacute rejection in xenotransplantation.
- This genetic modification holds significant potential for advancing xenotransplantation research and applications.
- The developed technique has broad implications for both agricultural production and biomedical advancements using genetically modified swine.
Related Concept Videos
Introduction to Nuclear Reprogramming
2.2K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.2K
In-vitro Mutagenesis
15.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
15.9K
Methods of Nuclear Reprogramming
2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K